A Study of VIS410 to Assess Safety and Pharmacokinetics
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, immunogenicity and
pharmacokinetics of single escalating doses of VIS410 in healthy volunteers.